AstraZeneca & Isis Pharmaceuticals partnership to discover and develop antisense drugs
Posted on04 Aug 2015
Tagsantisense oligonucleotides, AstraZeneca, AstraZeneca and Isis Pharmaceuticals, Isis Pharmaceuticals
Comments0
About the strategic collaboration: AstraZeneca and Isis Pharmaceuticals, Inc. announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic... Read More